ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 680

$916K Total Retail Price of All Prescriptions

Rank: 101 out of 680

477 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,857 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 644 536 1 2
AMLODIPINE BESYLATE 406 321 2 1
HYDROCHLOROTHIAZIDE 393 357 3 9
PRAVASTATIN SODIUM 392 290 4 10
HYDROCODONE-ACETAMINOPHEN 384 215 S3 5 4
OMEPRAZOLE 328 266 6 7
SIMVASTATIN 310 282 7 3
FUROSEMIDE 292 240 8 6
NAMENDA 291 270 9 35
METOPROLOL TARTRATE 251 195 10 12
DONEPEZIL HCL 244 229 11 27
GEMFIBROZIL 241 199 12 106
POTASSIUM CHLORIDE 236 194 13 14
GABAPENTIN 218 164 14 15
BISOPROLOL FUMARATE 184 176 15 173
WARFARIN SODIUM 179 119 16 20
DIOVAN 177 154 17 31
ESCITALOPRAM OXALATE 166 147 18 45
CLOPIDOGREL 166 148 18 26
ZOLPIDEM TARTRATE 161 123 20 17
POLYETHYLENE GLYCOL 3350 158 141 21 62
SERTRALINE HCL 154 128 22 28
LOSARTAN POTASSIUM 132 124 23 21
LISINOPRIL 129 93 24 5
TRAMADOL HCL-ACETAMINOPHEN 128 122 25 153
ALLOPURINOL 127 98 26 33
ATENOLOL 123 115 27 19
NOVOLIN N 121 75 28 225
NEXIUM 116 88 29 16
TAMSULOSIN HCL 116 114 29 34
PLAVIX 113 104 31 39
EXELON 112 112 32 112
TRAMADOL HCL 107 64 33 18
METFORMIN HCL 106 89 34 8
ENALAPRIL MALEATE 104 70 35 65
CITALOPRAM HBR 102 75 36 22
GLIMEPIRIDE 100 79 37 29
CARVEDILOL 100 97 37 23
CLONIDINE HCL 99 71 39 36
KLOR-CON M10 99 77 39 127
RISPERIDONE 99 62 39 80
LOVAZA 97 46 42 119
MELOXICAM 89 79 43 24
ATORVASTATIN CALCIUM 89 66 43 11
JANTOVEN 85 73 45 147
CYMBALTA 83 51 46 46
ALENDRONATE SODIUM 81 75 47 32
MIRTAZAPINE 80 53 48 78
QUETIAPINE FUMARATE 80 47 48 64
HUMULIN N 73 63 50 246
TRICOR 72 46 51 98
FAMOTIDINE 72 51 51 89
NOVOLOG 70 52 53 167
FINASTERIDE 70 65 53 109
DIVALPROEX SODIUM 67 34 55 110
CIPROFLOXACIN HCL 67 60 55 57
LABETALOL HCL 67 39 55 158
METOPROLOL SUCCINATE 67 49 55 13
CYCLOBENZAPRINE HCL 65 60 R 59 81
OLANZAPINE 64 52 60 116
MEGESTROL ACETATE 64 54 R 60 88
DIVALPROEX SODIUM ER 62 24 62 148
FLUTICASONE PROPIONATE 62 58 62 41
AZITHROMYCIN 61 47 64 42
CRESTOR 60 50 65 25
SPIRONOLACTONE 60 53 65 82
NOVOLIN R 59 51 67 113
ISOSORBIDE MONONITRATE ER 58 53 68 59
DETROL LA 58 27 68 169
CELEBREX 57 44 70 90
BENZTROPINE MESYLATE 55 14 R 71 137
FLUOXETINE HCL 55 42 71 74
PREDNISONE 54 35 73 50
NIFEDIPINE ER 53 43 74 75
PENTOXIFYLLINE 52 52 75 356
TRILIPIX 51 29 76 264
DILTIAZEM 24HR CD 50 50 77 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.